BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Farmers Insurance

Generated: December 15, 2017

DrugPatentWatch Database Preview

ATENOLOL Drug Profile

« Back to Dashboard

When do Atenolol patents expire, and when can generic versions of Atenolol launch?

Atenolol is a drug marketed by Able, Alvogen Malta, Apothecon, Aurobindo Pharma, Dava Pharms Inc, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, Sandoz, SCS, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Unique Pharm Labs, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, and Mutual Pharm. and is included in forty-one NDAs.

The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Watson LabsATENOLOL AND CHLORTHALIDONEatenolol; chlorthalidoneTABLET;ORAL073665-002Jul 2, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds IncATENOLOLatenololTABLET;ORAL078210-002Jul 10, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozATENOLOLatenololTABLET;ORAL074052-001May 1, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaATENOLOLatenololTABLET;ORAL073316-001May 28, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms UsaATENOLOLatenololTABLET;ORAL076900-003Jan 28, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm IndustriesATENOLOLatenololTABLET;ORAL073476-001Mar 30, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaATENOLOLatenololTABLET;ORAL074056-002Jan 18, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Unique Pharm LabsATENOLOLatenololTABLET;ORAL077443-003Sep 13, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Alvogen MaltaATENOLOL AND CHLORTHALIDONEatenolol; chlorthalidoneTABLET;ORAL072301-001May 31, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Nostrum LabsATENOLOLatenololTABLET;ORAL074127-002Feb 21, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: